Kistler-Tiffany Companies’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $6.01K | Hold |
42
| – | – | ﹤0.01% | 749 |
|
|
2023
Q1 | $5.83K | Hold |
42
| – | – | ﹤0.01% | 676 |
|
|
2022
Q4 | $5.7K | Hold |
42
| – | – | ﹤0.01% | 681 |
|
|
2022
Q3 | $5K | Sell |
42
-8
| -16% | -$1.01K | ﹤0.01% | 671 |
|
|
2022
Q2 | $7K | Hold |
50
| – | – | ﹤0.01% | 619 |
|
|
2022
Q1 | $7K | Hold |
50
| – | – | ﹤0.01% | 638 |
|
|
2021
Q4 | $6K | Hold |
50
| – | – | ﹤0.01% | 635 |
|
|
2021
Q3 | $6K | Sell |
50
-461
| -90% | -$53.7K | ﹤0.01% | 630 |
|
|
2021
Q2 | $61K | Hold |
511
| – | – | 0.01% | 333 |
|
|
2021
Q1 | $51K | Hold |
511
| – | – | 0.01% | 332 |
|
|
2020
Q4 | $51K | Hold |
511
| – | – | 0.01% | 299 |
|
|
2020
Q3 | $56K | Buy |
511
+461
| +922% | +$51.3K | 0.02% | 259 |
|
|
2020
Q2 | $5K | Sell |
50
-117
| -70% | -$12.1K | ﹤0.01% | 502 |
|
|
2020
Q1 | $17K | Hold |
167
| – | – | 0.01% | 376 |
|
|
2019
Q4 | $17K | Hold |
167
| – | – | 0.01% | 383 |
|
|
2019
Q3 | $15K | Hold |
167
| – | – | 0.01% | 400 |
|
|
2019
Q2 | $14K | Hold |
167
| – | – | 0.01% | 402 |
|
|
2019
Q1 | $13K | Hold |
167
| – | – | 0.01% | 395 |
|
|
2018
Q4 | $13K | Hold |
167
| – | – | 0.01% | 367 |
|
|
2018
Q3 | $13K | Hold |
167
| – | – | 0.01% | 393 |
|
|
2018
Q2 | $12K | Buy |
167
+117
| +234% | +$8.42K | 0.01% | 395 |
|
|
2018
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 514 |
|
|
2017
Q4 | $3K | Sell |
50
-102
| -67% | -$6.88K | ﹤0.01% | 505 |
|
|
2017
Q3 | $10K | Hold |
152
| – | – | ﹤0.01% | 415 |
|
|
2017
Q2 | $10K | Hold |
152
| – | – | ﹤0.01% | 399 |
|
|
2017
Q1 | $9K | Hold |
152
| – | – | ﹤0.01% | 404 |
|
|
2016
Q4 | $8K | Hold |
152
| – | – | ﹤0.01% | 417 |
|
|
2016
Q3 | $10K | Sell |
152
-25
| -14% | -$1.63K | ﹤0.01% | 427 |
|
|
2016
Q2 | $11K | Sell |
177
-475
| -73% | -$27.6K | 0.01% | 421 |
|
|
2016
Q1 | $37K | Hold |
652
| – | – | 0.02% | 276 |
|
|
2015
Q4 | $44K | Hold |
652
| – | – | 0.02% | 266 |
|
|
2015
Q3 | $41K | Sell |
652
-636
| -49% | -$41.8K | 0.02% | 266 |
|
|
2015
Q2 | $82K | Buy |
1,288
+636
| +98% | +$43.5K | 0.05% | 202 |
|
|
2015
Q1 | $45K | Hold |
652
| – | – | 0.03% | 246 |
|
|
2014
Q4 | $46K | Sell |
652
-619
| -49% | -$44.3K | 0.03% | 245 |
|
|
2014
Q3 | $91K | Buy |
1,271
+1,119
| +736% | +$81.9K | 0.06% | 184 |
|
|
2014
Q2 | $11K | Hold |
152
| – | – | 0.01% | 421 |
|
|
2014
Q1 | $10K | Hold |
152
| – | – | 0.01% | 420 |
|
|
2013
Q4 | $9K | Hold |
152
| – | – | 0.01% | 439 |
|
|
2013
Q3 | $8K | Hold |
152
| – | – | 0.01% | 439 |
|
|
2013
Q2 | $7K | Buy |
+152
| New | +$7.74K | 0.01% | 444 |
|
Other funds holding AZN
Kistler-Tiffany Companies's AZN Position: Q2 2023 in Review
Kistler-Tiffany Companies held its AstraZeneca (AZN) position steady in Q2 2023 at 42 shares worth $6.01K. The position accounts for ﹤0.01% of the portfolio, ranked #749.
Kistler-Tiffany Companies first reported a position in AZN in Q2 2013 and has held it in 41 quarters since. The position peaked at $91K in Q3 2014. 1,092 funds tracked by Wall St. Rank hold AZN as of Q2 2023.
- Kistler-Tiffany Companies held 42 shares of AstraZeneca worth $6.01K as of Q2 2023.
- Kistler-Tiffany Companies left its AstraZeneca share count unchanged in Q2 2023.
- AstraZeneca made up ﹤0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #749 holding.
- Kistler-Tiffany Companies first reported a position in AstraZeneca in Q2 2013 and has held it in 41 quarters since.
- Kistler-Tiffany Companies's AstraZeneca position peaked at $91K in Q3 2014.
- 1,092 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2023.
Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.